Steven Cohen's AUTL Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 426,983 shares of Autolus Therapeutics plc (AUTL) worth $589,237, representing 0.00% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in AUTL, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 305,359 shares. Largest reduction occurred in Q1 2025, reducing 212,444 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Autolus Therapeutics plc (AUTL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Autolus Therapeutics plc (AUTL) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +121,624 | Add 39.83% | 426,983 | $1.38 |
| Q4 2025 | +305,359 | New Buy | 305,359 | $1.99 |
| Q3 2025 | -71,400 | Sold Out | 0 | $0.00 |
| Q2 2025 | +36,755 | Add 106.09% | 71,400 | $2.28 |
| Q1 2025 | -212,444 | Reduce 85.98% | 34,645 | $1.55 |
| Q4 2024 | +247,089 | New Buy | 247,089 | $2.35 |
| Q2 2024 | -37,300 | Sold Out | 0 | $0.00 |
| Q1 2024 | +37,300 | New Buy | 37,300 | $6.38 |
| Q2 2020 | -124,463 | Sold Out | 0 | $0.00 |
| Q1 2020 | -191,341 | Reduce 60.59% | 124,463 | $5.99 |
| Q4 2019 | +238,150 | Add 306.68% | 315,804 | $13.20 |
| Q3 2019 | +77,654 | New Buy | 77,654 | $12.41 |
Steven Cohen's Autolus Therapeutics plc Investment FAQs
Steven Cohen first purchased Autolus Therapeutics plc (AUTL) in Q3 2019, acquiring 77,654 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Autolus Therapeutics plc (AUTL) for 12 quarters since Q3 2019.
Steven Cohen's largest addition to Autolus Therapeutics plc (AUTL) was in Q4 2025, adding 305,359 shares worth $607,664.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 426,983 shares of Autolus Therapeutics plc (AUTL), valued at approximately $589,237.
As of the Q1 2026 filing, Autolus Therapeutics plc (AUTL) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Autolus Therapeutics plc (AUTL) was 426,983 shares, as reported at the end of Q1 2026.